Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin for Glycemic Variability in T2DM on Premixed Insulin
NCT04654676Phase 4Completed
- Sponsor
- Universiti Malaysia Sarawak
- Start
- Sep 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Universiti Malaysia Sarawak. Started Sep 2018; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04654676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04654676.